ATE325110T1 - Sauerstoff enthaltende heterocyclische verbindungen - Google Patents

Sauerstoff enthaltende heterocyclische verbindungen

Info

Publication number
ATE325110T1
ATE325110T1 AT96915194T AT96915194T ATE325110T1 AT E325110 T1 ATE325110 T1 AT E325110T1 AT 96915194 T AT96915194 T AT 96915194T AT 96915194 T AT96915194 T AT 96915194T AT E325110 T1 ATE325110 T1 AT E325110T1
Authority
AT
Austria
Prior art keywords
bond
containing heterocyclic
cyano
combined
heterocyclic compounds
Prior art date
Application number
AT96915194T
Other languages
English (en)
Inventor
Takashi Kawakita
Etsuo Ohshima
Koji Yanagawa
Kyoichiro Iida
Rie Koike
Michio Ichimura
Haruhiko Manabe
Kenji Ohmori
Fumio Suzuki
Yoshisuke Nakasato
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE325110T1 publication Critical patent/ATE325110T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Furan Compounds (AREA)
AT96915194T 1995-05-19 1996-05-20 Sauerstoff enthaltende heterocyclische verbindungen ATE325110T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12153795 1995-05-19
JP25865195 1995-10-05

Publications (1)

Publication Number Publication Date
ATE325110T1 true ATE325110T1 (de) 2006-06-15

Family

ID=26458881

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96915194T ATE325110T1 (de) 1995-05-19 1996-05-20 Sauerstoff enthaltende heterocyclische verbindungen

Country Status (13)

Country Link
EP (1) EP0771794B1 (de)
JP (1) JP4172817B2 (de)
KR (1) KR100445356B1 (de)
CN (1) CN1163493C (de)
AT (1) ATE325110T1 (de)
AU (1) AU705690B2 (de)
CA (1) CA2195755A1 (de)
DE (1) DE69636086T2 (de)
DK (1) DK0771794T3 (de)
ES (1) ES2258775T3 (de)
NO (1) NO317631B1 (de)
PT (1) PT771794E (de)
WO (1) WO1996036624A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59610077D1 (de) * 1995-05-18 2003-02-27 Altana Pharma Ag Phenyldihydrobenzofurane
JPH11505539A (ja) * 1995-05-18 1999-05-21 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング シクロヘキシルジヒドロベンゾフラン
CZ292443B6 (cs) * 1995-12-05 2003-09-17 Darwin Discovery Limited Benzofuransulfonamid, farmaceutický prostředek jej obsahující a jeho použití
NZ332340A (en) * 1996-05-20 2000-04-28 Darwin Discovery Ltd 4-(aryl or heteroaryl) substituted benzofurancarboxamide derivatives and medicaments
JP4309475B2 (ja) * 1996-08-19 2009-08-05 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規のベンゾフラン―4―カルボキサミド
AU4967697A (en) * 1996-11-19 1998-06-10 Kyowa Hakko Kogyo Co. Ltd. Oxygenic heterocyclic compounds
JP4219554B2 (ja) * 1997-10-01 2009-02-04 協和発酵キリン株式会社 ベンゾフラン誘導体
CA2317478A1 (en) * 1998-02-09 1999-08-12 Darwin Discovery Limited Benzofuran-4-carboxamides and their therapeutic use
PT1095040E (pt) * 1998-07-06 2004-08-31 Altana Pharma Ag Novos benzoxazoles com actividade inibidora da pde
ES2224747T3 (es) 1998-09-03 2005-03-01 Kyowa Hakko Kogyo Co., Ltd. Compuestos heterociclicos que contienen oxigeno.
EP1141278B1 (de) * 1998-12-30 2008-02-27 Oligos Etc. Inc. Therapeutische pde4d phosphodiesterase inhibitoren
AU6315300A (en) * 1999-07-26 2001-02-13 Shionogi & Co., Ltd. Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same
WO2003000697A1 (en) * 2001-06-22 2003-01-03 Takeda Chemical Industries, Ltd. Furoisoquinoline derivative, process for producing the same, and use
DE10205274A1 (de) * 2002-02-08 2003-08-21 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen
DE10216427A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Arzneimittelkompositionen enthaltend heterocyclische Verbindungen und ein neues Anticholinergikum
JPWO2004005276A1 (ja) * 2002-07-03 2005-11-04 協和醗酵工業株式会社 1,3−ベンゾジオキソール−2−スピロシクロアルカン誘導体の製造法
EP1621196A4 (de) * 2003-03-17 2007-03-21 Kyowa Hakko Kogyo Kk Therapeutisches und/oder präventives mittel für chronische hautkrankheiten
WO2004087151A1 (ja) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co., Ltd. 医薬組成物
EP1616569A1 (de) * 2003-03-31 2006-01-18 Kyowa Hakko Kogyo Co., Ltd. Medizinische zusammensetzung
WO2004087146A1 (ja) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co., Ltd. 微粒子混合物の製造方法
WO2004087150A1 (ja) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co. Ltd. 医薬組成物
CA2520779A1 (en) * 2003-03-31 2004-11-11 Kyowa Hakko Kogyo Co., Ltd. Agent for intra-airway administration
JPWO2004087148A1 (ja) * 2003-03-31 2006-06-29 協和醗酵工業株式会社 肺疾患の治療および/または予防剤
TW200503706A (en) * 2003-03-31 2005-02-01 Kyowa Hakko Kogyo Kk Treating and/or preventing agent for pulmonary diseases
WO2004112791A1 (ja) * 2003-06-23 2004-12-29 Kyowa Hakko Kogyo Co., Ltd. 肺疾患の治療および/または予防剤
EP1504756A1 (de) * 2003-08-06 2005-02-09 Kyowa Hakko Kogyo Co., Ltd Arzneimittelkompositionen enthaltend eine heterocyclischen Verbindung und ein Anticholinergikum
CA2584169A1 (en) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. Remedies/preventives for chronic skin disease
US20080085858A1 (en) * 2004-10-13 2008-04-10 Kyowa Hakko Kogyo Co., Ltd. Pharmaceutical Composition
WO2006123726A1 (ja) * 2005-05-18 2006-11-23 Kyowa Hakko Kogyo Co., Ltd. 医薬組成物
JPWO2008026687A1 (ja) * 2006-09-01 2010-01-21 杏林製薬株式会社 ピラゾロピリジンカルボキサミド誘導体及びそれらを含有するホスホジエステラーゼ(pde)阻害剤
EP2060572A4 (de) * 2006-09-06 2010-11-17 Kyorin Seiyaku Kk Pyrazolopyridin-derivat und dieses als wirkstoff enthaltende phosphodiesterase (pde)-hemmer
BRPI0721113A2 (pt) * 2006-12-22 2014-10-07 Leo Pharma As Composto, composição farmacêutica, uso de um composto, e, método para prevenir, tratar ou melhorar doenças ou condições dérmicas ou distúrbios
SI2114951T1 (sl) * 2007-02-28 2014-08-29 Leo Pharma A/S Novi zaviralci fosfodiesteraze
ES2380395T3 (es) 2007-04-16 2012-05-11 Leo Pharma A/S Triazolopiridinas como inhibidores de fosfodiesterasa para el tratamiento de enfermedades dérmicas
SI2379548T1 (sl) 2008-12-19 2016-06-30 Leo Pharma A/S Triazolopiridini kot fosfodiesterazni inhibitorji za zdravljenje kožnih bolezni
NZ603895A (en) 2010-06-24 2014-10-31 Leo Pharma As Novel phosphodiesterase inhibitors
PL2794603T3 (pl) 2011-12-21 2017-08-31 Leo Pharma A/S [1,2,4]triazolopirydyny i ich zastosowanie jako inhibitory fosfodiesterazy
BR112016029510A2 (pt) * 2014-06-23 2017-08-22 Leo Pharma As métodos para a preparação de um composto, e, composto intermediário.
CN106588841B (zh) * 2015-10-19 2019-01-25 富乐马鸿凯(大连)医药有限公司 合成2,3-二氢-1-苯并呋喃-4-甲醛的方法
CN106588900A (zh) * 2015-10-20 2017-04-26 北京康辰医药科技有限公司 一种苯并双环化合物或其药学上可接受的盐、药物组合物及其应用
CN106905336B (zh) * 2017-01-22 2019-04-09 浙江工业大学 一种手性吡唑螺呋喃类化合物的不对称合成方法
CN107325067B (zh) * 2017-05-03 2020-05-12 广州中医药大学 磷酸二酯酶4抑制剂桑辛素m衍生物及其用途
DK3642210T3 (da) 2017-06-20 2024-12-09 Union Therapeutics As Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
CN109721580B (zh) * 2017-10-27 2022-11-04 中国医学科学院药物研究所 3-苯基-7,8-脱氢葡萄藤戊素衍生物、其制法和药物组合物与用途
CN109721579B (zh) * 2017-10-27 2022-11-04 中国医学科学院药物研究所 7,8-脱氢葡萄藤戊素衍生物、其制法和药物组合物与用途
CN114478413B (zh) * 2022-01-14 2023-06-23 北京富盛嘉华医药科技有限公司 2-(2′-羟基-3′-甲代烯丙基-5′-甲基苯基)苯并三氮唑的制备方法及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2507604A2 (fr) * 1977-04-19 1982-12-17 Delalande Sa Nouvelles trimethoxy-3,4,5 cinnamoyle piperazines, leur procede de preparation et leur application en therapeutique
CA1297877C (en) * 1983-12-22 1992-03-24 Daniel Lednicer Benzofurancarboxamides useful as antiemetic or antipsychotic agents
JPS62234083A (ja) * 1986-02-28 1987-10-14 アーバモント インク ディビーエイ アドリヤ ラボラトリーズ 鎮吐薬または精神病治療薬として有用なカルボキサミド類
JPH01207267A (ja) * 1987-03-05 1989-08-21 Yamanouchi Pharmaceut Co Ltd ピリジン誘導体及び該化合物を含有する肝疾患治療剤
ZA886585B (en) * 1987-09-08 1990-05-30 Lilly Co Eli Specific 5-ht,antagonists
US5366986A (en) * 1988-04-15 1994-11-22 T Cell Sciences, Inc. Compounds which inhibit complement and/or suppress immune activity
ES2102036T3 (es) * 1992-06-15 1997-07-16 Celltech Therapeutics Ltd Derivados con grupo fenilo trisustituido utilizados como inhibidores selectivos de la fosfodiesterasa iv.
FI970246L (fi) * 1994-07-22 1997-01-21 Byk Gulden Lomberg Chem Fab Dihydrobentsofuraanit
DE59610077D1 (de) * 1995-05-18 2003-02-27 Altana Pharma Ag Phenyldihydrobenzofurane

Also Published As

Publication number Publication date
CN1154697A (zh) 1997-07-16
ES2258775T3 (es) 2006-09-01
NO970151L (no) 1997-03-06
DE69636086D1 (de) 2006-06-08
NO317631B1 (no) 2004-11-29
CN1163493C (zh) 2004-08-25
CA2195755A1 (en) 1996-11-21
HK1000785A1 (en) 2006-06-30
EP0771794B1 (de) 2006-05-03
KR970704724A (ko) 1997-09-06
KR100445356B1 (ko) 2004-11-12
DE69636086T2 (de) 2006-11-30
NO970151D0 (no) 1997-01-14
PT771794E (pt) 2006-09-29
EP0771794A4 (de) 1998-09-02
WO1996036624A1 (en) 1996-11-21
DK0771794T3 (da) 2006-09-11
JP4172817B2 (ja) 2008-10-29
EP0771794A1 (de) 1997-05-07
AU5702996A (en) 1996-11-29
AU705690B2 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
DE69636086D1 (de) Sauerstoff enthaltende heterocyclische verbindungen
ATE338754T1 (de) Heterocyclische verbindungen, ihre herstellung und verwendung
NO953305D0 (no) Antranilsyrederivat
DE69918695D1 (de) Sauerstoffhaltige heterocyclische verbindungen
ATE263771T1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
DE69505470D1 (de) Pyrrolocarbazol
DK0719277T3 (da) Androstenoner
FI900461A0 (fi) Imidazopyridaziner, deras framstaellning och anvaendning.
DE69106902D1 (de) Imidazopyridazine, ihre Herstellung und Verwendung.
ATE174916T1 (de) Imidazopyridazine als antiasthmatika
AU695633B2 (en) Arylpiperidine and arylpiperazine derivatives and medicament containing the same
ES2112489T3 (es) Derivados carboxilato que presentan una actividad inhibidora de la fosfolipasa a2.
FI895229A0 (fi) Foereningar foer behandling av urininkontinens och framstaellning daerav.
DE69526332D1 (de) Indol-derivate
DE69214180D1 (de) Verwendung von Bis-(p-Hydroxyphenylthio)methanderivaten zur Hemmung der fortschreitenden Entwicklung von insulinabhängingem Diabetes mellitus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0771794

Country of ref document: EP

REN Ceased due to non-payment of the annual fee